GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 9.82

Change

-0.12 (-1.21)%

Market Cap

N/A

Volume

0.39M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-2.53 (-1.96%)

USD 76.31B
VTR Ventas Inc

-1.06 (-1.63%)

USD 26.53B
DOC Healthpeak Properties Inc

-0.30 (-1.32%)

USD 15.39B
CTRE CareTrust REIT Inc.

-0.37 (-1.19%)

USD 4.68B
AHR American Healthcare REIT, Inc.

-0.29 (-1.10%)

USD 4.04B
NHI National Health Investors Inc

-0.62 (-0.73%)

USD 3.62B
LTC LTC Properties Inc

-0.55 (-1.49%)

USD 1.60B
UHT Universal Health Realty Income..

-0.86 (-1.86%)

USD 0.63B
CHCT Community Healthcare Trust Inc

+0.39 (+2.28%)

USD 0.47B
GMRE-PA Global Medical REIT Inc

+0.10 (+0.37%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.61 % 0.35 %

-0.17 (0%)

USD 0.27B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.53% 14% F 13% F
Dividend Return 5.68% 79% B- 85% B
Total Return -5.86% 14% F 15% F
Trailing 12 Months  
Capital Gain 10.09% 21% F 38% F
Dividend Return 9.42% 93% A 91% A-
Total Return 19.51% 29% F 47% F
Trailing 5 Years  
Capital Gain -14.76% 46% F 26% F
Dividend Return 35.85% 100% F 89% A-
Total Return 21.09% 54% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain -3.24% 43% F 22% F
Dividend Return 3.50% 43% F 42% F
Total Return 6.74% 79% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.06% 36% F 41% F
Risk Adjusted Return 13.98% 36% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.